Cargando…

Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases

Beta-lactamases represent the main bacterial mechanism of resistance to beta-lactam antibiotics and are a significant challenge to modern medicine. We have developed an automated classification and analysis protocol that exploits structure- and sequence-based approaches and which allows us to propos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, David, Das, Sayoni, Dawson, Natalie L., Dobrijevic, Dragana, Ward, John, Orengo, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917113/
https://www.ncbi.nlm.nih.gov/pubmed/27332861
http://dx.doi.org/10.1371/journal.pcbi.1004926
_version_ 1782438911628279808
author Lee, David
Das, Sayoni
Dawson, Natalie L.
Dobrijevic, Dragana
Ward, John
Orengo, Christine
author_facet Lee, David
Das, Sayoni
Dawson, Natalie L.
Dobrijevic, Dragana
Ward, John
Orengo, Christine
author_sort Lee, David
collection PubMed
description Beta-lactamases represent the main bacterial mechanism of resistance to beta-lactam antibiotics and are a significant challenge to modern medicine. We have developed an automated classification and analysis protocol that exploits structure- and sequence-based approaches and which allows us to propose a grouping of serine beta-lactamases that more consistently captures and rationalizes the existing three classification schemes: Classes, (A, C and D, which vary in their implementation of the mechanism of action); Types (that largely reflect evolutionary distance measured by sequence similarity); and Variant groups (which largely correspond with the Bush-Jacoby clinical groups). Our analysis platform exploits a suite of in-house and public tools to identify Functional Determinants (FDs), i.e. residue sites, responsible for conferring different phenotypes between different classes, different types and different variants. We focused on Class A beta-lactamases, the most highly populated and clinically relevant class, to identify FDs implicated in the distinct phenotypes associated with different Class A Types and Variants. We show that our FunFHMMer method can separate the known beta-lactamase classes and identify those positions likely to be responsible for the different implementations of the mechanism of action in these enzymes. Two novel algorithms, ASSP and SSPA, allow detection of FD sites likely to contribute to the broadening of the substrate profiles. Using our approaches, we recognise 151 Class A types in UniProt. Finally, we used our beta-lactamase FunFams and ASSP profiles to detect 4 novel Class A types in microbiome samples. Our platforms have been validated by literature studies, in silico analysis and some targeted experimental verification. Although developed for the serine beta-lactamases they could be used to classify and analyse any diverse protein superfamily where sub-families have diverged over both long and short evolutionary timescales.
format Online
Article
Text
id pubmed-4917113
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49171132016-07-08 Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases Lee, David Das, Sayoni Dawson, Natalie L. Dobrijevic, Dragana Ward, John Orengo, Christine PLoS Comput Biol Research Article Beta-lactamases represent the main bacterial mechanism of resistance to beta-lactam antibiotics and are a significant challenge to modern medicine. We have developed an automated classification and analysis protocol that exploits structure- and sequence-based approaches and which allows us to propose a grouping of serine beta-lactamases that more consistently captures and rationalizes the existing three classification schemes: Classes, (A, C and D, which vary in their implementation of the mechanism of action); Types (that largely reflect evolutionary distance measured by sequence similarity); and Variant groups (which largely correspond with the Bush-Jacoby clinical groups). Our analysis platform exploits a suite of in-house and public tools to identify Functional Determinants (FDs), i.e. residue sites, responsible for conferring different phenotypes between different classes, different types and different variants. We focused on Class A beta-lactamases, the most highly populated and clinically relevant class, to identify FDs implicated in the distinct phenotypes associated with different Class A Types and Variants. We show that our FunFHMMer method can separate the known beta-lactamase classes and identify those positions likely to be responsible for the different implementations of the mechanism of action in these enzymes. Two novel algorithms, ASSP and SSPA, allow detection of FD sites likely to contribute to the broadening of the substrate profiles. Using our approaches, we recognise 151 Class A types in UniProt. Finally, we used our beta-lactamase FunFams and ASSP profiles to detect 4 novel Class A types in microbiome samples. Our platforms have been validated by literature studies, in silico analysis and some targeted experimental verification. Although developed for the serine beta-lactamases they could be used to classify and analyse any diverse protein superfamily where sub-families have diverged over both long and short evolutionary timescales. Public Library of Science 2016-06-22 /pmc/articles/PMC4917113/ /pubmed/27332861 http://dx.doi.org/10.1371/journal.pcbi.1004926 Text en © 2016 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lee, David
Das, Sayoni
Dawson, Natalie L.
Dobrijevic, Dragana
Ward, John
Orengo, Christine
Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
title Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
title_full Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
title_fullStr Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
title_full_unstemmed Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
title_short Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
title_sort novel computational protocols for functionally classifying and characterising serine beta-lactamases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917113/
https://www.ncbi.nlm.nih.gov/pubmed/27332861
http://dx.doi.org/10.1371/journal.pcbi.1004926
work_keys_str_mv AT leedavid novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases
AT dassayoni novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases
AT dawsonnataliel novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases
AT dobrijevicdragana novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases
AT wardjohn novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases
AT orengochristine novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases